Incidence of Nivolumab-Induced Pneumonitis and Interstitial Lung Disease (ILD) in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): A Combined Analysis of Four Phase III Randomized Controlled Trials
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI